One 97 Communications Paytm, Zomato, APL Apollo Tubes, Central Bank of India, Dixon Technologies, IDBI Bank, Indian Overseas Bank, Indian Railway Finance Corporation, ICICI Securities, Jammu ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins and acquisitions, here’s a quick look at which stocks will be ...

The trend is also visible in other FMCG companies. Zydus Wellness, the company behind brands like Complan and Glucon-D, is expanding its rural coverage, focusing on increasing penetration where brands ...

WASHINGTON — Paul Mango, an integral part of the Trump administration’s drive to invent coronavirus vaccines and treatments, has died at 65. Mango joined former President Trump’s Health and ...

Covid vaccines saved lives. Lots of them. Research by the World Health Organization (WHO) now puts the number at 475,000 in the UK with many more kept out of hospital or off a ventilator.

Babies are supposed to receive vaccines that protect against about 15 different infectious diseases. Most require more than one dose, which amounts to nearly 30 jabs by age two. Parents may be ...

In its original form, the virus survives in just two countries. But a type linked to an oral vaccine used in other nations has already turned up in the West. By Apoorva Mandavilli Most American ...

The declines began with the pandemic, well before routine vaccines became part of the national political conversation. By Francesca Paris After years of holding steady, American vaccination rates ...

The flu season is in full swing, but Europeans are less protected due to falling vaccination levels among at-risk groups. An estimated 27,600 people die from the flu every year in the European ...

Federal funding for COVID-19 vaccines will stop this year and the provinces and territories will be responsible for buying them, as well as determining the timing of the vaccinations, the Public ...

Zydus' domestic businesses are expected to contribute 44% of Ebitda by fiscal 2027, said Nomura, supported by investments in vaccines and specialty drugs, alongside potential for value-accretive ...

There is no antiviral treatment for the miserable but thankfully short-lived illness, and no vaccine—yet. But scientists at Moderna are in the late stages of testing what could be the first such ...